Area of expertise:
- Diagnostic and therapeutic endoscopy (gastroscopy and colonoscopy)
- Inflammatory bowel disease (Crohn’s disease, ulcerative colitis, microscopic colitis)
- Liver diseases
- Bowel cancer screening
- Anaemia and gastrointestinal bleeding (capsule endoscopy)
- Coeliac disease
- Dyspepsia and reflux
- Functional bowel disease, irritable bowel syndrome, chronic diarrhoea, constipation
Qualifications:
- MBChB (Otago) 2007, FRACP 2015
Training:
- Undergraduate: Otago Medical School, University of Otago 2002-2007
- Basic and advanced physician training: Gastroenterology and General Medicine 2008-2016
- Post fellowship training: Senior inflammatory bowel disease fellow, Royal Brisbane and Women’s Hospital, Brisbane, Australia 2017-2018
Current employment:
- Consultant gastroenterologist and general physician, Middlemore Hospital 2018
Additional language skills:
- Mandarin, Cantonese, Teochew, Hokkien, Malay
Memberships:
- New Zealand Society of Gastroenterology
- Auckland Chinese Medical Association
Research:
Publications:
2018 | Lim MH, Radford-Smith GL. Editorial: First among equals – not for either infliximab or adalimumab in Crohn’s disease – yet. Aliment Pharmacol Ther 2018; 47 (8):1225-1226 |
2017 | Lim MH, Aluzaite K, Schultz M, Casey P. Infliximab trough levels: a comparison between the Quantum Blue infliximab rapid assay and the established ELISA. Journal of Gastroenterology and Hepatology 2017; 32 (Suppl 2):132 |
2017 | Lim MH, Radford-Smith GL. Editorial: Faecal microbiota transplantation for ulcerative colitis – not quite there yet? Aliment Pharmacol Ther 2017; 46 (6):630-631 |
2016 | Lim MH, Faire B, Beban G, Orr DW. Reliability of transient elastography for the detection of fibrosis in severely obese patients. Hepatol Int 2016; 10:S1-S506 |
2015 | Lim MH, Phipps-Green M, Merriman T, Schultz M. Association of NOD2 mutations with disease phenotype in an Otago cohort of patients with Crohn’s disease. NZMJ 2015; 128 (1408) |
2014 | Orr DW, Lim MH, McCall JL, Bartlett, Gane EJ. Years of liver transplant assessments for hepatocellular carcinoma: a single centre experience. Hepatol Int 2014; 8:S1-S405 |
2014 | Lim MH, Gane EJ, Orr DW. Years of liver transplant assessments for chronic liver disease: a single centre experience. Hepatol Int 2014; 8:S1-S405 |
2014 | Lim MH, Smith W, Larsen P. Is the risk/benefit ratio for cardiac defibrillators implanted in an older population (age ≥ 75) still favourable? NZMJ 2014; 127 (1388) |
2013 | Lim MH, Gane EJ, Orr DW. Years of liver transplant assessments for chronic liver disease: a single centre experience. NZMJ 2013; 126 (1387) |
2013 | Lim MH, Garrett J, Mowlem L, Yap E. Diagnosing malignant pleural effusions: how do we compare? NZMJ 2013; 126 (1381) |
Oral presentations:
2018 | Australian Gastroenterology Week: Have changes in medical therapy and surgical techniques for ulcerative colitis altered post colectomy outcomes over the past 26 years? |
2017 | New Zealand Society of Gastroenterology Annual Scientific Meeting: Infliximab trough levels: a comparison between the Quantum Blue infliximab rapid assay and the established ELISA |
2017 | Australian Gastroenterology Week: Infliximab trough levels: a comparison between the Quantum Blue infliximab rapid assay and the established ELISA |
2016 | New Zealand Society of Gastroenterology Annual Scientific Meeting: Large sessile high grade dysplastic colorectal polyps can be managed successfully endoscopically |
2015 | New Zealand Society of Gastroenterology Annual Scientific Meeting: Reliability of transient elastography for the detection of fibrosis in severely obese patients |
2014 | New Zealand Society of Gastroenterology Annual Scientific Meeting: Association of NOD2 mutations with disease phenotype in an Otago cohort of patients with Crohn’s disease |
2014 | The Asian Pacific Association for the Study of the Liver: Years of liver transplant assessments for chronic liver disease: a single centre experience |
2014 | The Asian Pacific Association for the Study of the Liver: Years of liver transplant assessments for hepatocellular carcinoma: a single centre experience |
2013 | New Zealand Society of Gastroenterology Annual Scientific Meeting: 15 years of liver transplant assessments for chronic liver disease: a single centre experience |
2013 | Cardiac Society of New Zealand Annual Scientific Meeting: Is the risk/benefit ratio for cardiac defibrillators implanted in an older population (age ≥ 75) still favourable? |
Clinical trial experience:
Year | Trial name (Condition) | Role | Type | Phase |
---|---|---|---|---|
2018 | SHP647-302 (Ulcerative colitis) | Sub investigator | Industry | 3 |
2018 | B7581002 (Ulcerative colitis) | Sub investigator | Industry | 2a |
2017 | RHB-104-01 (Crohn’s disease) | Sub investigator | Industry | 3 |
2017 | PTG-100-02 (Ulcerative colitis) | Sub investigator | Industry | 2b |
2017 | GA29102 (Ulcerative colitis) | Sub investigator | Industry | 3 |
2017 | GA28950 (Ulcerative colitis) | Sub investigator | Industry | 3 |
2017 | GA28951 (Ulcerative colitis) | Sub investigator | Industry | 3 |
2017 | GA29144 (Crohn’s disease) | Sub investigator | Industry | 3 |
2016 | GA27927 (Ulcerative colitis) | Sub investigator | Industry | 2/3 |
2016 | GS-US326-1100 (Ulcerative colitis) | Sub investigator | Industry | 2/3 |
2016 | GS-US-395-1663 (Crohn’s disease) | Sub investigator | Industry | 2 |
2016 | 747-303 (Non alcoholic steatohepatitis) | Sub investigator | Industry | 3 |
2016 | Heparc-2008 (Hepatitis B) | Sub investigator | Industry | 2 |
2016 | ARC5211001 (Hepatitis B) | Sub investigator | Industry | 1a/1b |